-
IntroducedFeb 18, 2021
-
Passed House
-
Passed Senate
-
Signed into Law
Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Last Action See all actions
House • Apr 09, 2021: Author stricken Boe
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HF 1183
Tweets
Whip Lists
Sponsors
- Stephenson
- Bierman
- Klevorn
- Greenman
Votes
Looks like there aren't any voting records available at this moment.
Actions
- Apr 09, 2021 | House
- Author stricken Boe
- Mar 25, 2021 | House
- Author added Greenman
- Mar 11, 2021 | House
- Committee report, to adopt and re-refer to Ways and Means
- Mar 09, 2021 | House
- Committee - State Government Finance and Elections
- Mar 08, 2021 | House
- Author added Klevorn
- Mar 04, 2021 | House
- Committee report, to adopt as amended and re-refer to State Government Finance and Elections
- Author added Bierman
- Mar 02, 2021 | House
- Committee - Health Finance and Policy
- Feb 25, 2021 | House
- Committee report, to adopt as amended and re-refer to Health Finance and Policy
- Author added Boe
- Feb 24, 2021 | House
- Committee - Commerce Finance and Policy
- Feb 23, 2021 | House
- Committee - Commerce Finance and Policy
- Feb 18, 2021 | House
- Introduction and first reading, referred to Commerce Finance and Policy
Report a comment
×
Do you want to add this event to your calendar?